FOXJ2 has been suggested to function as a tumor suppressor gene in breast cancer cells, glioma cells, cholangiocarcinoma cells, HCC cells, and non–small-cell lung cancer, and low expression levels of FOXJ2 indicates poor prognosis of cancer patients [17,19,27,28]. This evidence concerns the gene FOXJ2 and breast carcinoma.